147 related articles for article (PubMed ID: 7123514)
1. Dosage frequency for suppression of platelet function by low dose aspirin therapy.
Bradlow BA; Chetty N
Thromb Res; 1982 Jul; 27(1):99-110. PubMed ID: 7123514
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent.
De Caterina R; Giannessi D; Gazzetti P; Bernini W
Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876
[No Abstract] [Full Text] [Related]
3. Long-term ultra-low-dose aspirin therapy and platelet function.
Chetty N; Atkinson PM; Bradlow BA
S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the production of thromboxane B2 and malondialdehyde by human blood platelets.
Best LC; Jones PB; Russell RG
Clin Sci (Lond); 1980 Aug; 59(2):131-5. PubMed ID: 7190885
[No Abstract] [Full Text] [Related]
5. Low-dose aspirin in pregnancy.
Sibai BM; Mirro R; Chesney CM; Leffler C
Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.
Stef G; Csiszar A; Ziangmin Z; Ferdinandy P; Ungvari Z; Veress G
Pharmacol Rep; 2007; 59(4):428-36. PubMed ID: 17901572
[TBL] [Abstract][Full Text] [Related]
8. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
Gorczynska E; James M; Wegrzynowicz R; Masiak M
Wiad Lek; 1985 Jul; 38(13):920-5. PubMed ID: 3933184
[No Abstract] [Full Text] [Related]
9. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
Terres W; Schuster O; Kupper W; Bleifeld W
Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
11. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
12. The influence of aspirin on plasma and platelet catecholamine levels, and platelet function in normal man.
Smith CC; Wilson AP; Betteridge DJ
Clin Auton Res; 1993 Feb; 3(1):49-53. PubMed ID: 8477181
[TBL] [Abstract][Full Text] [Related]
13. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
[TBL] [Abstract][Full Text] [Related]
14. Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.
Weksler BB; Kent JL; Rudolph D; Scherer PB; Levy DE
Stroke; 1985; 16(1):5-9. PubMed ID: 3966266
[TBL] [Abstract][Full Text] [Related]
15. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
[TBL] [Abstract][Full Text] [Related]
16. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
17. Development of aspirin resistance in persons with previous ischemic stroke.
Helgason CM; Bolin KM; Hoff JA; Winkler SR; Mangat A; Tortorice KL; Brace LD
Stroke; 1994 Dec; 25(12):2331-6. PubMed ID: 7974569
[TBL] [Abstract][Full Text] [Related]
18. A circulating inhibitor of platelet aggregation in Bartter's syndrome.
O'Reagan SO; Rivard GE; Mongeau JG; Robitaille PO
Pediatrics; 1979 Dec; 64(6):939-41. PubMed ID: 117424
[TBL] [Abstract][Full Text] [Related]
19. Effects of mitoxantrone and bisantrene on platelet aggregation and prostaglandin/thromboxane biosynthesis in vitro.
Frank P; Novak RF
Anticancer Res; 1986; 6(5):941-7. PubMed ID: 3467648
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin.
Ring ME; Corrigan JJ; Fenster PE
Thromb Res; 1986 Nov; 44(3):391-400. PubMed ID: 3798404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
